Recombinant Human SLAMF2 (C-mFc)

Recombinant Human SLAMF2 (C-mFc)

规格:10µg      价格:¥690
规格:50µg      价格:¥1800
规格:500µg    价格:¥10980
SKU: PHH2034 Category: 靶点蛋白 Tags: , ,

说明书 复制

产品名称

Recombinant Human SLAMF2 (C-mFc)

英文名称

CD48/SLAMF2/SLAM Family Member 2/BCM1/BLAST1  

纯度

Greater than 95% as determined by reducing SDS-PAGE

内毒素

<1 EU/µg as determined by LAL test.

蛋白构建

Recombinant Human SLAM Family Member 2 is produced by our Mammalian expression system and the target gene encoding Gln27-Ser220 is expressed with a mouse IgG1 Fc tag at the C-terminus.

Accession

P09326

表达宿主

Human Cells

种属

Human

预测分子量

48.9 KDa

制剂

Lyophilized from a 0.2 μm filtered solution of 20 mM Tris-HCl, 150mM NaCl, pH 8.0.

运输方式

The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below.

稳定性&储存

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

复溶

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

分子别名
CD48 antigen; B-lymphocyte activation marker BLAST-1; BCM1 surface antigen; Leukocyte antigen MEM-102; TCT.1; CD48; BCM1; BLAST1

 

背景介绍
CD48 antigen, also known as B-lymphocyte activation marker BLAST-1, BCM1 surface antigen, Leukocyte antigen MEM-102, TCT.1, CD48, BCM1,and BLAST1, CD48 contains one Ig-like C2-type domain and one Ig-like V-type domain, but does not have a transmembrane domain, however, but is held at the cell surface by a GPI anchor via a C-terminal domain which maybe cleaved to yield a soluble form of the receptor. CD48 may facilitate interaction between activated lymphocytes and be involved in regulating T-cell activation. CD48 plays a vital role as an environmental sensor for regulating progenitor cell numbers and inhibiting tumor development. It is suggested that the anti-CD48 mAb has the potential to become an effective therapeutic mAb against multiple myeloma.

 

注意事项

本司产品仅用于科研,不用于临床诊断和治疗

 


  • 027-87002838

  • order@enkilife.cn

  • 微信客服
  • 企业微信
  • 在线留言
    关闭